NEWS & EVENTS

2010, July 23rd

CPhI

We will attend CPhI Worldwide, Paris, 5th÷7th, October 2010

Technologies improved

Daunomycin 3 ± 0.3 g/l

Coenzyme Q10 3.5 ± 0.5 g/l

Clavulanic acid 8 ± 0.5 g/l

Teicoplanin

Reached higher titre in Harvest Broth with a new fermentation approach:

6±0.5 g/L in pilot scale

ISO certificate

HOME
Biofin Laboratories brings a technical and managerial experience in industrial fermentation technology and biotechnology.
HISTORY
Industrial fermentation technology for bulk production of APIs, antibiotic, anticancer, aminoacid, vitamin and bioproducts in general, is our background.
SERVICES
Technology transfer is our work in the last twenty years with the international world of the biotechnology.
TECHNOLOGIES PORTFOLIO
Technologies producing antibiotic, anticancer, Active Pharmaceutical Ingredients (APIs) and bio-products in general.
- > Antibiotics
- > Other APIs
- > Other bioproducts
- > Enzymes
- > Semi-synthesis technologies
PARTNERSHIP
Practical experience in the scale up of bulk production technologies.
ORGANIZATION
Flexible, custom oriented and leader with industrial background.
GALLERY
Our industrial bioprocesses are practically tested in our plant. Microbiology laboratories, Fermenter pilot plant, Down-stream phase plant, Semisynthesis laboratory, Analysis laboratory, Engineering.
CONTACT
Biofin Laboratories has long experience in international cooperation for the industrial biotechnology.